Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study using nine years of data from University Hospital Zurich. It combines medical records with follow-up questionnaires to describe long-term reproductive outcomes after vacuum-induced tamponade for postpartum hemorrhage. The goal is to understand potential effects on fertility, subsequent pregnancies, and related complications. The study will descriptively report how often secondary infertility or other issues occur following VIT treatment. No interventions are performed as part of this study beyond data collection and patient follow-up.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women ≥ 18 years of age.
* Delivery at the USZ between January 2017 and December 2025. Documented postpartum hemorrhage managed with VIT.
* Provision of written informed consent

Exclusion Criteria:

* Decline of informed consent.
* Inability to establish contact (e.g., incorrect address, telephone number not reachable, moved abroad).
* Women who are unable to provide informed consent (e.g., due to language barriers without translation support, or cognitive impairment).

Where it's running

• University Hospital Zurich, Department of Obstetrics
  Zurich, Canton of Zurich, Switzerland Recruiting

Study contacts

• Study coordinator: Christian Haslinger, Prof. Dr
• Email: christian.haslinger@usz.ch
• Phone: +41432537575

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Calcium Gluconate After Birth to Reduce Blood Loss in Vaginal Delivery

  This study tests whether giving calcium gluconate right after the baby is born can help reduce blood loss for people having a vaginal delivery.

  Recruiting Rambam Health Care Campus · Haifa · NCT07714902

• Carbetocin Alone vs Carbetocin Plus Oxytocin After Elective Cesarean Delivery

  This study tests whether giving carbetocin by itself after an elective cesarean is just as good as adding a supplemental oxytocin infusion.

  Recruiting Phase 4 Mansoura University · Buraidah, Al-Qassim Region · NCT07636421

• Flumazenil to help reduce cognitive side effects during ECT for depression

  This study tests whether giving flumazenil to reverse benzodiazepine effects during electroconvulsive therapy can lower cognitive side effects without reducing treatment effectiveness in adults with depression.

  Recruiting Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Frederiksberg, Capital Region · NCT07619092

• Simulation-based postpartum hemorrhage training to boost anesthesiology team performance

  Senior anesthesiology residents will try a high-fidelity simulation program for postpartum hemorrhage to see if it improves how their teams perform during obstetric emergencies.

  Recruiting Hacettepe University · Ankara, Ankara · NCT07519252

• Home-based Acute Care for Older Adults Initiated by Emergency Services

  A team-based, home-delivered acute care approach for people 75+ is being studied to see if it can match the results of usual ED care in terms of care needs and mortality.

  Recruiting Vastra Gotaland Region · Gothenburg · NCT07472335

• Carbetocin to prevent heavy bleeding after twin birth

  This trial tests whether a single dose of carbetocin given after the second twin is born reduces heavy bleeding compared with standard oxytocin in people delivering twins.

  Recruiting Phase 4 Sheba Medical Center · Ramat Gan · NCT07401524

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.